Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind, Placebo Controlled Phase III Trial to Determine the Efficacy and Safety of Topical Intra-oral Ketoprofen for the Treatment of Acute Migraine

NCT01228552 is registered in ClinicalTrials.gov with Behar, Caren, M.D. as lead sponsor.

NCT NCT01228552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01228552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind, Placebo Controlled Phase III Trial to Determine the Efficacy and Safety of Topical Intra-oral Ketoprofen for the Treatment of Acute Migraine
Lead sponsor
Behar, Caren, M.D.
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2011
Completion date
January 31, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine, migraine, migraine disorders, migraine headache